Critical evaluation of gamma-irradiated serum used as feeder in the culture and demonstration of putative nanobacteria and calcifying nanoparticles

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Martel, Jan ^a   Wu, Cheng Yeu ^a   Young, John D ^a,b,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b ROCKEFELLER UNIVERSITY   (United States)

^c MING CHI UNIVERSITY OF TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FETUIN A; HYBRID PROTEIN; NANOPARTICLE; PLASMA PROTEIN; CALCIUM;

ARTICLE; BACTERIUM; BODY FLUID; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; GAMMA IRRADIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL CULTURE; NANOBACTERIA; PRECIPITATION; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEOMICS; RADIATION DOSE; SERUM; CYTOLOGY; GAMMA RADIATION; INSTRUMENT STERILIZATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; RADIATION EXPOSURE;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BLOOD PROTEINS; CALCIUM; GAMMA RAYS; HUMANS; NANOPARTICLES; SERUM; STERILIZATION;

EID: 77956398500     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010343     Document Type: Article

References (128)

1. Martel J, Young JD (2008) Purported nanobacteria in human blood as calcium carbonate nanoparticles. Proc Natl Acad Sci USA 105: 5549-5554.
2. Young JD, Martel J, Young L, Wu CY, Young A, et al. (2009) Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS ONE 4: e4417.
3. Young JD, Martel J, Young D, Young A, Hung CM, et al. (2009) Characterization of granulations of calcium and apatite in serum as pleomorphic mineralo-protein complexes and as precursors of putative nanobacteria. PLoS ONE 4: e5421.
4. Wu CY, Martel J, Young D, Young JD (2009) Fetuin-A/albumin-mineral complexes resembling serum calcium granules and putative nanobacteria: demonstration of a dual inhibition-seeding concept. PLoS ONE 4: e8058.
5. Young JD, Martel J (2010) The rise and fall of nanobacteria. Sci Am 302: 52-59.
6. Kajander EO, Kuronen I, Akerman K, Pelttari A, Ciftcioglu N (1997) Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth. Proc Soc Photo Opt Instrum Eng 3111: 420-428.
7. Ciftcioglu N, Kuronen I, Akerman K, Hiltunen E, Laukkanen J, et al. (1997) A new potential threat in antigen and antibody products: nanobacteria. In: Brown F, Burton D, Doherty P, Mekalanos J, Norrby E, eds. Vaccines 97. Molecular approaches to the control of infectious diseases. New York: Cold Spring Harbor Laboratory Press. pp 99-103.
8. Kajander EO, Ciftcioglu N (1998) Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci USA 95: 8274-8279.
9. Carson DA (1998) An infectious origin of extraskeletal calcification. Proc Natl Acad Sci USA 95: 7846-7847.
10. Dorrell S (1999) Nanobacteria linked to kidney disease. Mol Med Today 5: 373.
11. Ciftcioglu N, Bjorklund M, Kuorikoski K, Bergstrom K, Kajander EO (1999) Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 56: 1893-1898.
12. Hjelle JT, Miller-Hjelle MA, Poxton IR, Kajander EO, Ciftcioglu N, et al. (2000) Endotoxin and nanobacteria in polycystic kidney disease. Kidney Int 57: 2360-2374.
13. Kajander EO, Ciftcioglu N, Aho K, Garcia-Cuerpo E (2003) Characteristics of nanobacteria and their possible role in stone formation. Urol Res 31: 47-54.
14. Kajander EO (2006) Nanobacteria-propagating calcifying nanoparticles. Lett Appl Microbiol 42: 549-552.
15. Ciftcioglu N, McKay DS, Mathew G, Kajander EO (2006) Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel selfreplicating, calcifying nanoparticles. J Investig Med 54: 385-394.
16. Kumar V, Farell G, Yu S, Harrington S, Fitzpatrick L, et al. (2006) Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cellmediated calcification, and nanoparticles. J Investig Med 54: 412-424.
17. Ciftcioglu N, Aho KM, McKay DS, Kajander EO (2007) Are apatite nanoparticles safe? Lancet 369: 2078.
18. Ciftcioglu N, Vejdani K, Lee O, Mathew G, Aho KM, et al. (2008) Association between Randall's plaque and calcifying nanoparticles. Int J Nanomedicine 3: 105-115.
19. Lieske JC (2008) Can biologic nanoparticles initiate nephrolithiasis? Nature Clin Pract Nephrol 4: 308-309.
20. Shiekh FA, Miller VM, Lieske JC (2009) Do calcifying nanoparticles promote nephrolithiasis? A review of the evidence. Clin Nephrol 71: 1-8.
21. Urbano P, Urbano F (2007) Nanobacteria: facts or fancies? PLoS Pathog 3: e55.
22. Cisar JO, Xu DQ, Thompson J, Swaim W, Hu L, et al. (2000) An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci USA 97: 11511-11515.
23. Drancourt M, Jacomo V, Lepidi H, Lechevallier E, Grisoni V, et al. (2003) Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J Clin Microbiol 41: 368-372.
24. Raoult D, Drancourt M, Azza S, Nappez C, Guieu R, et al. (2008) Nanobacteria are mineralo fetuin complexes. PLoS Pathog 4: e41.
25. Jones JA, Ciftcioglu N, Schmid JF, Barr YR, Griffith D (2009) Calcifying nanoparticles (nanobacteria): an additional potential factor for urolithiasis in space flight crews. Urology 73: e11-e13.
26. Zhang SM, Tian F, Jiang XQ, Li J, Xu C, et al. (2009) Evidence for calcifying nanoparticles in gingival crevicular fluid and dental calculus in periodontitis. J Periodontol 80: 1462-1470.
27. Zhang QH, Lu GS, Shen XC, Zhou ZS, Fang Q, et al. (2009) Nanobacteria may be linked to testicular microlithiasis in infertility. J Androl. In press.
28. Hu YR, Zhao Y, Sun YW, Lu WD, Liu ZL, et al. (2009) Detection of nanobacteria-like material from calcified cardiac valves with rheumatic heart disease. Cardiovasc Pathol. In press.
29. Zhang QH, Shen XC, Zhou ZS, Chen ZW, Lu GS, et al. (2010) Decreased nanobacteria levels and symptoms of nanobacteria-associated interstitial cystitis/painful bladder syndrome after tetracycline treatment. Int Urogynecol J Pelvic Floor Dysfunct 21: 103-109.
30. Ciftcioglu N, Kajander EO (1998) Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 4: 259-270.
31. Ciftcioglu N, Miller-Hjelle MA, Hjelle JT, Kajander EO (2002) Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother 46: 2077-2086.
32. Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, et al. (2004) Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol 287: H1115-H1124.
33. Wen Y, Li YG, Yang ZL, Wang XJ, Wei H, et al. (2005) Detection of nanobacteria in serum, bile and gallbladder mucosa of patients with cholecystolithiasis. Chin Med J (Engl) 118: 421-424.
34. Wang L, Shen W, Wen J, An X, Cao L, et al. (2006) An animal model of black pigment gallstones caused by nanobacteria. Dig Dis Sci 51: 1126-1132.
35. Zhou HD, Li GY, Yang YX, Li XL, Sheng SR, et al. (2006) Intracellular colocalization of SPLUNC1 protein with nanobacteria in nasopharyngeal carcinoma epithelia HNE1 cells depended on the bactericidal permeability increasing protein domain. Mol Immunol 43: 1864-1871.
36. Zhou Z, Hong L, Shen X, Rao X, Jin X, et al. (2008) Detection of nanobacteria infection in type III prostatitis. Urology 71: 1091-1095.
37. Bratos-Perez MA, Sanchez PL, Garcia de Cruz S, Villacorta E, Palacios IF, et al. (2008) Association between self-replicating calcifying nanoparticles and aortic stenosis: a possible link to valve calcification. Eur Heart J 29: 371-376.
38. Schwartz MA, Lieske JC, Kumar V, Farell-Baril G, Miller VM (2008) Humanderived nanoparticles and vascular response to injury in rabbit carotid arteries: proof of principle. Int J Nanomedicine 3: 243-248.
39. Bjorklund M, Ciftcioglu N, Kajander EO (1998) Extraordinary survival of nanobacteria under extreme conditions. Proc Soc Photo Opt Instrum Eng 3441: 123-129.
40. Ciftcioglu N, Kajander EO (1999) Growth factors for nanobacteria. Proc Soc Photo Opt Instrum Eng 3755: 113-119.
41. Folk RL (1993) SEM imaging of bacteria and nannobacteria in carbonate sediments and rocks. J Sediment Petrol 63: 990-999.
42. Sillitoe RH, Folk RL, Sarie N (1996) Bacteria as mediators of copper sulfide enrichment during weathering. Science 272: 1153-1155.
43. Sommer AP, Gheorghiu E, Cehreli M, Mester AR, Whelan HT (2006) Biosensor for detection of nanobacteria in water. Cryst Growth Des 6: 492-497.
44. Smirnov GV, Smirnov DG (2008) Nannobacteria, a new ecological threat. Contemp Prob Ecol 1: 111-114.
45. Sommer AP, Wickramasinghe NC (2005) Functions and possible provenance of primordial proteins-Part II: microorganism aggregation in clouds triggered by climate change. J Proteome Res 4: 180-184.
46. McKay DS, Gibson EK, Jr., Thomas-Keprta KL, Vali H, Romanek CS, et al. (1996) Search for past life on Mars: possible relic biogenic activity in martian meteorite ALH84001. Science 273: 924-930.
47. Wainwright M, Wickramasinghe NC, Narlikar JV, Rajaratnam P (2003) Microorganisms cultured from stratospheric air samples obtained at 41 km. FEMS Microbiol Lett 218: 161-165.
48. Wickramasinghe NC, Narlikar JV, Rajaratnam P (2004) Are these stratospheric nanoparticles bacteria? Microbiology 150: 756-758.
49. Wickramasinghe JT, Wickramasinghe NC (2006) A cosmic prevalence of nanobacteria? Astrophys Space Sci 305: 411-413.
50. Kajander EO, Ciftcioglu N (1999) Nanobacteria as extremophiles. Proc Soc Photo Opt Instrum Eng 3755: 106-112.
51. Schwartz MK, Hunter LW, Huebner M, Lieske JC, Miller VM (2009) Characterization of biofilm formed by human-derived nanoparticles. Nanomed 4: 931-941.
52. Miller VM, Hunter LW, Chu K, Vivasvat K, Squillace PD, et al. (2009) Biologic nanoparticles and platelet reactivity. Nanomed 4: 725-733.
53. Schwartz MK, Lieske JC, Hunter LW, Miller VM (2009) Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits. Am J Physiol Heart Circ Physiol 296: H1434-1441.
54. Vali H, McKee MD, Ciftcioglu N, Sears SK, Plows FL, et al. (2001) Nanoforms: a new type of protein-associated mineralization. Geochim Cosmochim Acta 65: 63-74.
55. Sambrook J, Russell DW (2001) Quantification of nucleic acids. In: Argentine J, ed. Molecular cloning. A laboratory manual (third edition). New York: Cold Spring Harbor Laboratory Press. pp A8.19-A8.21.
56. Zhang S, Gerhard GS (2008) Heme activates artemisinin more efficiently than hemin, inorganic iron, or hemoglobin. Bioorg Med Chem 16: 7853-7861.
57. Zhang S, Gerhard GS (2009) Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target. PLoS ONE 4: e7472.
58. Giroux M, Lacroix M (1998) Nutritional adequacy of irradiated meat-a review. Food Res Int 31: 257-264.
59. Grieb T, Forng RY, Brown R, Owolabi T, Maddox E, et al. (2002) Effective use of gamma irradiation for pathogen inactivation of monoclonal antibody preparations. Biologicals 30: 207-216.
60. Lacroix M, Ouattara B (2000) Combined industrial processes with irradiation to assure innocuity and preservation of food products-a review. Food Res Int 33: 719-724.
61. Vitek L, Ostrow JD (2009) Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des 15: 2869-2883.
62. Iqbal MS, Shad MA, Akhtar MA (2001) The effect of gamma-radiation on bilirubin. J Radioanal Nuc Chem 250: 397-398.
63. Pillay AE, Salih FM (2003) A comparative study on gamma irradiation of unconjugated bilirubin in aqueous and non-aqueous solutions. Anal Bioanal Chem 375: 751-755.
64. Du J, Gebicki JM (2004) Proteins are major initial cell targets of hydroxyl free radicals. Int J Biochem Cell Biol 36: 2334-2343.
65. Grootveld M, Halliwell B, Hill HAO (1986) An aromatic hydroxylation assay for hydroxyl radicals utilizing high-performance liquid chromatography (HPLC). Use to investigate the effect of EDTA on the Fenton reaction. Free Rad Res 1: 243-250.
66. Hicks M, Gebicki JM (1986) Rate constants for reaction of hydroxyl radicals with Tris, Tricine and Hepes buffers. FEBS Lett 199: 92-94.
67. Yu BP (1994) Cellular defenses against damage from reactive oxygen species. Physiol Rev 74: 139-162.
68. Clarkson PM, Thompson HS (2000) Antioxidants: what role do they play in physical activity and health? Am J Clin Nutr 72: 637-646.
69. Johansson L, Klinth J, Holmqvist O, Ohlson S (2003) Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnology 42: 67-74.
70. Wong F (2007) Drug insight: the role of albumin in the management of chronic liver disease. Nature Clin Pract Gastroenterol Hepatol 4: 43-51.
71. Brown WM, Saunders NR, Mollgard K, Dziegielewska KM (1992) Fetuin-an old friend revisited. Bioessays 14: 749-755.
72. Hendig D, Schulz V, Arndt M, Szliska C, Kleesiek K, et al. (2006) Role of serum fetuin-A, a major inhibitor of systemic calcification, in pseudoxanthoma elasticum. Clin Chem 52: 227-234.
73. Vivian JT, Callis PR (2001) Mechanisms of tryptophan fluorescence shifts in proteins. Biophys J 80: 2093-2109.
74. Eftink MR (2000) Intrinsic fluorescence of proteins. In: Lakowicz JR, ed. Protein fluorescence. Topics in fluorescence spectroscopy. New York: Kluwer Academic/Plenum Publishers. pp 1-15.
75. Johansson JS (1997) Binding of the volatile anesthetic chloroform to albumin demonstrated using tryptophan fluorescence quenching. J Biol Chem 272: 17961-17965.
76. Naseem F, Khan RH, Haq SK, Naeem A (2003) Characterization of molten globule state of fetuin at low pH. Biochim Biophys Acta 1649: 164-170.
77. Jackson M, Mantsch HH (1995) The use and misuse of FTIR spectroscopy in the determination of protein structure. Crit Rev Biochem Mol Biol 30: 95-120.
78. Barth A (2007) Infrared spectroscopy of proteins. Biochim Biophys Acta 1767: 1073-1101.
79. Dogan A, Siyakus G, Severcan F (2007) FTIR spectroscopic characterization of irradiated hazelnut (Corylus avellana L.). Food Chem 100: 1106-1114.
80. Toyran N, Zorlu F, Donmez G, Oge K, Severcan F (2004) Chronic hypoperfusion alters the content and structure of proteins and lipids of rat brain homogenates: A Fourier transform infrared spectroscopy study. Eur Biophys J 33: 549-554.
81. Maruyama T, Katoh S, Nakajima M, Nabetani H (2001) Mechanism of bovine serum albumin aggregation during ultrafiltration. Biotechnol Bioeng 75: 233-238.
82. Charbonneau D, Beauregard M, Tajmir-Riahi HA (2009) Structural analysis of human serum albumin complexes with cationic lipids. J Phys Chem B 113: 1777-1784.
83. Li Y, He W, Dong Y, Sheng F, Hu Z (2006) Human serum albumin interaction with formononetin studied using fluorescence anisotropy, FT-IR spectroscopy, and molecular modeling methods. Bioorg Med Chem 14: 1431-1436.
84. Militello V, Casarino C, Emanuele A, Giostra A, Pullara F, et al. (2004) Aggregation kinetics of bovine serum albumin studied by FTIR spectroscopy and light scattering. Biophys Chem 107: 175-187.
85. Griebenow K, Klibanov AM (1995) Lyophilization-induced reversible changes in the secondary structure of proteins. Proc Natl Acad Sci USA 92: 10969-10976.
86. Gorne-Tschelnokow U, Naumann D, Weise C, Hucho F (1993) Secondary structure and temperature behaviour of acetylcholinesterase. Studies by Fourier-transform infrared spectroscopy. Eur J Biochem 213: 1235-1242.
87. Kato A, Takagi T (1988) Formation of intermolecular beta-sheet structure during heat denaturation of ovalbumin. J Agric Food Chem 36: 1156-1159.
88. Lee Y, Song KB (2002) Effect of gamma-irradiation on the molecular properties of myoglobin. J Biochem Mol Biol 35: 590-594.
89. Vuckovic M, Radojcic MB, Milosavljevic BH (2005) Gamma-radiation induced damage of proteins in the thick fraction of egg white. J Serbian Chem Soc 70: 1255-1262.
90. Cartellieri S, Hamer O, Helmholz H, Niemeyer B (2002) One-step affinity purification of fetuin from fetal bovine serum. Biotechnol Appl Biochem 35: 83-89.
91. Schinke T, Amendt C, Trindl A, Poschke O, Muller-Esterl W, et al. (1996) The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271: 20789-20796.
92. Heiss A, DuChesne A, Denecke B, Grotzinger J, Yamamoto K, et al. (2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278: 13333-13341.
93. Heiss A, Jahnen-Dechent W, Endo H, Schwahn D (2007) Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids. Biointerphases 2: 16-20.
94. Heiss A, Eckert T, Aretz A, Richtering W, van Dorp W, et al. (2008) Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J Biol Chem 283: 14815-14825.
95. Boskey AL (1991) The role of extracellular matrix components in dentin mineralization. Crit Rev Oral Biol Med 2: 369-387.
96. Boskey AL (2008) Mechanism of mineralization of collagen-based connective tissues. In: Sigel A, Sigel H, Sigel RKO, eds. Metal ions in life sciences. Volume 4. Biomineralization. From nature to application. Hoboken: John Wiley & Sons. pp 457-505.
97. Wopenka B, Pasteris JD (2005) A mineralogical perspective on the apatite in bone. Mat Sci Eng C 25: 131-143.
98. Pasteris JD, Wopenka B, Valsami-Jones E (2008) Bone and tooth mineralization: why apatite? Elements 4: 97-104.
99. Saroff HA, Lewis MS (1963) The binding of calcium ions to serum albumin. J Phys Chem 67: 1211-1216.
100. Fogh-Andersen N (1977) Albumin/calcium association at different pH, as determined by potentiometry. Clin Chem 23: 2122-2126.
101. Besarab A, DeGuzman A, Swanson JW (1981) Effect of albumin and free calcium concentrations on calcium binding in vitro. J Clin Pathol 34: 1361-1367.
102. Garnett J, Dieppe P (1990) The effects of serum and human albumin on calcium hydroxyapatite crystal growth. Biochem J 266: 863-868.
103. Gilman H, Hukins DW (1994) Seeded growth of hydroxyapatite in the presence of dissolved albumin. J Inorg Biochem 55: 21-30.
104. Gilman H, Hukins DW (1994) Seeded growth of hydroxyapatite in the presence of dissolved albumin at constant composition. J Inorg Biochem 55: 31-39.
105. Suzuki M, Shimokawa H, Takagi Y, Sasaki S (1994) Calcium-binding properties of fetuin in fetal bovine serum. J Exp Zool 270: 501-507.
106. Ciftcioglu N, McKay DS (2010) Pathological calcification and replicating calcifying-nanoparticles (CNP): general approach and correlation. Pediatr Res. In press.
107. Shiekh FA, Khullar M, Singh SK (2006) Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res 34: 53-57.
108. Garcia Cuerpo E, Kajander EO, Ciftcioglu N, Lovaco Castellano F, Correa C, et al. (2000) Nanobacteria. Un modelo de neo-litogenesis experimental. Arch Esp Urol 53: 291-303.
109. Jones JA, Ciftcioglu N, McKay D (2008) The role of nanobacteria/calcifying nanoparticles in prostate disease. In: Shoskes DA, ed. Current clinical urology series, chronic prostatitis/chronic pelvic syndrome. Totowa: Humana Press. pp 221-243.
110. Hohling HJ, Arnold S, Plate U, Stratmann U, Wiesmann HP (1997) Analysis of a general principle of crystal nucleation, formation in the different hard tissues. Adv Dent Res 11: 462-466.
111. Bonucci E (2002) Crystal ghosts and biological mineralization: fancy specters in an old castle, or neglected structures worthy of belief? J Bone Miner Metab 20: 249-265.
112. Robinson C (2007) Self-oriented assembly of nano-apatite particles: a subunit mechanism for building biological mineral crystals. J Dent Res 86: 677-679.
113. Olszta MJ, Cheng X, Jee SS, Kumar R, Kim Y-Y, et al. (2007) Bone structure and formation: a new perspective. Mat Sci Eng 58: 77-116.
114. Olde Loohuis KM, Jahnen-Dechent W, van Dorp W (2010) The case of mid R: milky ascites is not always chylous. Kidney Int 77: 77-78.
115. Price PA, Thomas GR, Pardini AW, Figueira WF, Caputo JM, et al. (2002) Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronatetreated rats. J Biol Chem 277: 3926-3934.
116. Price PA, Nguyen TM, Williamson MK (2003) Biochemical characterization of the serum fetuin-mineral complex. J Biol Chem 278: 22153-22160.
117. Price PA, Lim JE (2003) The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem 278: 22144-22152.
118. Price PA, Williamson MK, Nguyen TM, Than TN (2004) Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem 279: 1594-1600.
119. Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, et al. (2009) Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int 75: 915-928.
120. Doherty TM, Asotra K, Fitzpatrick LA, Qiao J-H, Wilkin DJ, et al. (2003) Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci USA 100: 11201-11206.
121. Giachelli CM (2004) Vascular calcification mechanisms. J Am Soc Nephrol 15: 2959-2964.
122. Abedin M, Tintut Y, Demer LL (2004) Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 24: 1161-1170.
123. Speer MY, Giachelli CM (2004) Regulation of cardiovascular calcification. Cardiovasc Pathol 13: 63-70.
124. Shroff RC, Shanahan CM (2007) The vascular biology of calcification. Semin Dial 20: 103-109.
125. Susi H, Byler DM (1986) Resolution-enhanced Fourier transform infrared spectroscopy of enzymes. Methods Enzymol 130: 290-311.
126. Akerman KK, Kuikka JT, Ciftcioglu N, Parkkinen J, Bergstrom KA, et al. (1997) Radiolabeling and in vivo distribution of nanobacteria in rabbit. Proc Soc Photo Opt Instrum Eng 3111: 436-443.
127. Puskas LG, Tiszlavicz L, Razga Z, Torday LL, Krenacs T, et al. (2005) Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung 56: 233-245.
128. Franiczek R, Szufnarowski K, Czarny A, Zaczynska E, Krzyzanowska B, et al. (2009) Occurrence of calcifying nanoparticles in clinical specimens derived from patients with atherosclerosis and nephrolithiasis. Adv Clin Exp Med 18: 269-275.